RxDoctor Payments Data

Traci Evans-Ellacott

Adult Health · Cleveland, OHNPI 1588634976

Payments from drug & device makers

$892in general payments, 2019–2025

Across 40 payments — averaging $22.29 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Johnson & Johnson$178
  • Heartflow, Inc.$140
  • Boehringer Ingelheim$99
  • E.r. Squibb & Sons, L.L.C.$99
  • Novartis$96
  • Astellas Pharma US Inc$90
  • plus $190 from 7 others

What the payments were for

  • Food & beverage$81591%
  • Education$779%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
23
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$892 in reported general payments places this provider in the 65th percentile of 1,184 adult health providers in Ohio.

See all adult health providers in Ohio

Medicare billing

Part B allowed, 2024
$73,563
Medicare patients
594
Services billed
711

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban650$744,920
XareltoRivaroxaban131$134,667
EntrestoSacubitril/Valsartan54$66,686
Dofetilide164$18,845
Amiodarone Hcl264$7,247
Flecainide Acetate115$7,095
SotalolSotalol Hcl182$5,978
Metoprolol Succinate431$5,518
Diltiazem 24hr Er (Cd)Diltiazem Hcl151$4,741
Digoxin158$4,093
Warfarin Sodium211$3,547
Diltiazem 12hr ErDiltiazem Hcl12$3,521
Propafenone Hcl ErPropafenone Hcl20$2,988
Metoprolol Tartrate402$2,726
Mexiletine Hcl14$2,561

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$25$744,920650 claims
Johnson & JohnsonXarelto$178$134,667131 claims
NovartisEntresto$96$66,68654 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 65th percentile of 1,184 adult health providers in Ohio.

Other adult health in Cleveland

See the full list for Ohio

Where these figures come from

Is this you, or does something look wrong? →